Overview
August 1-2, 2008
New York, NY
Changes in Treatment Paradigm for Lung Cancer: Recent Advances
August 1-2, 2008 – The Westin New York at Times Square, 270 West 43rd Street, New York, NY 10036 – PHONE: 212-201-2700
Target Audience
This symposium is directed primarily to medical oncologists, radiation oncologists, surgical oncologists, pharmacists, researchers and registered nurses interested in new developments for treatment of lung cancer. No specific skill or knowledge other than a basic training in oncology is required for successful participation in this activity. Fellows are also invited to attend.
Statement of Need/Program Overview
This program is intended to provide comprehensive updates on biology, diagnosis, and management of lung cancer. Paradigm shift in the treatment options for lung cancer will be discussed. Treatment of subhistologies of NSCLC will be discussed in detail, and controversies in subtyping of adenocarcinoma will be outlined. In addition, this symposium will present data of most promising emerging agents currently in development for the treatment of lung cancer. The format will include didactic lectures from known thought leaders, question and answer sessions, and ample opportunity for participant interaction with faculty. Emerging data from ongoing clinical research will be presented.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and International Cancer Network. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this educational activity for a maximum of 11.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nursing Accreditation Statement
CNA/ANCC
This educational activity for 11.5 contact hours is provided by the Postgraduate Institute for Medicine.
PIM is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Roberta Granny prior to the live event at 717-531-1078.